The US Food and Drug Administration (FDA) is set to introduce a new ‘risk-based enforcement approach’ to homeopathic drugs in America, in a bid to protect consumers who choose to use alternative treatmentsThe US Food and Drug Administration (FDA) is to introduce a new ‘risk-based enforcement approach’ to drug products that are labeled ‘homeopathic’ and available on the American market.
In a bid to protect consumers who choose to use homeopathic products, the FDA is set to update existing policy to try to better address situations where homeopathic treatments are being marketed for serious diseases or conditions, but where the products have not been shown to offer clinical benefits.
Read more: http://bit.ly/2CAPQRH